Sign in

You're signed outSign in or to get full access.

Mary Paladino

Director at PHOTRONICSPHOTRONICS
Board

About Mary Paladino

Independent director at Photronics (PLAB) since 2019; age 63. Certified Public Accountant with 30+ years in accounting, auditing, and advisory for multinational companies. Currently EVP & CFO of Quality Medical Management Services USA, LLC; prior partner and audit/assurance practice leader at Citrin Cooperman; earlier leadership roles at Deloitte & Touche and BDO Seidman. Serves on PLAB’s Audit and Compensation Committees and is designated an “audit committee financial expert.”

Past Roles

OrganizationRoleTenureCommittees/Impact
Citrin Cooperman (White Plains, NY)Partner; Audit & Assurance practice leaderNot disclosedLed practice; complex accounting/reporting advisory
Deloitte & Touche LLPAuditing leadership rolesNot disclosedAudit, internal control and governance experience
BDO Seidman, LLPAuditing leadership rolesNot disclosedAudit and financial reporting experience

External Roles

OrganizationRoleTypeNotes
Quality Medical Management Services USA, LLCExecutive Vice President & Chief Financial OfficerPrivate management services (healthcare)Current role; non-clinical services to a large specialty medical practice

Board Governance

  • Independence and tenure

    • Independent under NASDAQ rules; director since 2019
    • Board met 6 times in FY2024; each director attended at least 75% of Board and committee meetings
    • All directors attended the 2024 annual meeting; current nominees expected to attend 2025 annual meeting
  • Committees and roles

    • Audit Committee member; designated “audit committee financial expert.” Audit Committee held 18 meetings in FY2024
    • Compensation Committee member
    • Served as Audit Committee Vice Chair and Chair at different times in FY2024 (prorated retainers paid; see compensation table below)
    • Note: Audit Committee chair to be re-elected April 2, 2025 following Mr. Fiederowicz’s departure; composition otherwise unchanged as of proxy filing
  • Board structure context (governance signal)

    • Lead Independent Director role currently vacant after longtime LID opted not to stand for re-election; Board may revisit the role in future
    • Executive Chairman is George C. Macricostas (son of founder-director Constantine S. Macricostas), which reduces overall independence of leadership (board-level consideration)

Fixed Compensation

  • Director cash compensation detail (FY2024, individual) | Component | Amount (USD) | Notes | |---|---:|---| | Annual cash retainer | $50,000 | Standard director retainer | | Audit Committee Chair retainer (prorated) | $20,000 | Served part of year as Chair (prorated) | | Audit Committee Vice Chair retainer (prorated) | $10,000 | Served part of year as Vice Chair (prorated) | | Compensation Committee member retainer | $15,000 | Committee service | | Meeting fees | $25,000 | 5 meetings at $5,000 per meeting (practice ended Sept 2024) | | Total FY2024 cash fees | $120,000 | Sum of above |

  • Director program (Calendar 2025, all non-employee directors) | Element | Amount/Terms | |---|---| | Annual cash retainer | $70,000 | | Committee retainers – Audit | Chair $40,000; Member $10,000 | | Committee retainers – Compensation | Chair $40,000; Member $7,500 | | Committee retainers – Nominating | Chair $20,000; Member $7,500 | | Committee retainers – Cyber Security | Chair $15,000; Member $7,500 |

Performance Compensation

  • Equity awards (directors) | Year | Award Type | Grant/Value | Vesting/Restrictions | Notes | |---|---|---:|---|---| | 2024 | Restricted Stock | 15,000 shares; grant-date FV $446,500 | Vests quarterly over one-year service period | Unvested as of 10/31/2024: 3,750 shares | | 2025 | Restricted Stock Units | $170,000 value-equivalent per director | Restrictions lapse on Apr 4, 2025; Jul 4, 2025; Oct 3, 2025; Jan 2, 2026 | Shift to value-based RSUs aligns with peer practices |

  • Metric design (directors): Director equity is time-vested; no performance metrics disclosed for director awards (time-based vesting only)

Other Directorships & Interlocks

CategoryDetails
Current public company boardsNone disclosed beyond PLAB
Prior public company boardsNot disclosed
Notable interlocks/conflictsNone disclosed for Paladino personally

Expertise & Qualifications

  • Certified Public Accountant; 30+ years in complex financial accounting and reporting, corporate governance, and internal controls
  • Audit Committee Financial Expert under Item 407 of Regulation S-K
  • CFO operating experience (healthcare management services), plus prior Big 4/mid-tier audit leadership roles

Equity Ownership

ItemAmountNotes
Beneficial ownership (common)69,000 sharesAs of Feb 7, 2025
Unvested restricted shares (director grant)3,750 sharesAs of Oct 31, 2024
Shares outstanding (context)63,560,209As of Feb 7, 2025 (record date)
Ownership as % of shares outstanding≈0.11%Calculated: 69,000 ÷ 63,560,209
Stock ownership guidelinesDirectors: 3x annual cash retainer (fixed-share method)All directors in compliance as of 10/31/2024

Hedging/pledging: Company prohibits hedging transactions by directors absent prior approval; policy strengthened in 2025. No pledging or hedging by Paladino is disclosed.

Governance Assessment

  • Strengths

    • Independent director; “audit committee financial expert”; active service on Audit and Compensation Committees; strong accounting and internal controls background
    • Solid engagement: Audit Committee met 18x in FY2024; each director ≥75% attendance; Paladino compensated for Audit Vice Chair and Chair service (suggesting elevated engagement)
    • Ownership alignment: Beneficial owner of 69,000 shares; in compliance with director ownership guidelines; ongoing time-vested equity grants
    • Compensation program practices: Directors’ 2025 shift to value-based RSUs and streamlined meeting-fee policy align with peer norms
  • Watch items

    • Board-level independence optics: No current Lead Independent Director; Executive Chairman is a family member of a long-tenured director (non-independent leadership structure). While not specific to Paladino, it may affect overall board independence perception.
    • Compensation Committee discretion: For executives, the Committee granted discretionary bonuses outside the 2011 EICP for FY2024—can be seen as a pay-governance flexibility signal; Paladino is a member of the Committee (not Chair). Monitor rationale and consistency over time.
    • Related-party exposure (company-level): CEO related to an individual at a major customer (no link to Paladino). Audit Committee oversees related-party transactions.
  • Additional signals

    • Clawback policy adopted in 2023 (SEC/stock exchange compliant) enhances governance infrastructure (primarily executive-focused)
    • No delinquent Section 16(a) filings disclosed for Paladino in FY2024

Director Compensation (FY2024 Detail)

NameFees Earned (Cash)Stock Awards (Grant-Date FV)Total
Mary Paladino$120,000$446,500$566,550
Notes$50k annual retainer; $20k Audit Chair (prorated); $10k Audit Vice Chair (prorated); $15k Comp member; $25k meeting fees15,000 restricted shares granted Jan 3, 2024; vests quarterly over one year
Citations

Committee Assignments (FY2024–FY2025 context)

CommitteeRoleNotes
AuditMember; Audit Committee Financial Expert18 meetings in FY2024; served as Vice Chair and Chair at different times in FY2024 (prorated retainers)
CompensationMemberMembership change: Garcia became Chair Jan 6, 2025; Paladino remained member
NominatingNot a member
Cyber SecurityNot a member

Say-on-Pay & Shareholder Feedback

  • Say‑on‑Pay approval at 2024 annual meeting (for FY2023 pay): 83.95% For. Committee retained Meridian Compensation Partners post‑FY2024 for benchmarking; independence assessed; recommendations aimed to align with peers (execs and directors).

Related-Party Transactions (Paladino-specific)

  • None disclosed for Paladino. Company-level related-party note pertains to CEO’s relation to a customer executive; Audit Committee oversees per policy.

Insider Filings

  • Section 16(a): No delinquent filings for Paladino disclosed in FY2024 (exceptions noted were for other individuals).